Title: ACMT and AACT position statement on preventing fentanyl analog exposure in emergency responders.<br/>Author: Hong Kim<br/><a href='http://umem.org/profiles/faculty/526/'>[Click to email author]</a><hr/><p> There have been reports of “intoxication” or adverse effects among first responders and law enforcement due to exposure to a “powder” suspected to be fentanyl or its analog.</p> <p> </p> <p> This has led to a significant concern among first responders and law enforcement when investigating or handling “powder” at the scene of overdose or drug enforcement related raids. (<a href="http://www.foxnews.com/health/2017/08/15/police-department-gets-hazmat-like-protective-gear-for-overdose-calls.html">http://www.foxnews.com/health/2017/08/15/police-department-gets-hazmat-like-protective-gear-for-overdose-calls.html</a>)</p> <p> </p> <p> American College of Medical Toxicology and American Association of Clinical Toxicology recently published a position statement to help clarify the potential health risk associated with exposure to fentanyl and its analogs.</p> <p> </p> <ol> <li> Opioid toxicity is unlikely from incidental dermal exposure.</li> <li> Nitrile gloves provide sufficient protection against dermal exposure.</li> <li> N95 respirator provide sufficient protection against aerosolize fentanyl/opioids.</li> <li> Naloxone should be administered for patients with objective signs of opioid toxicity - hypoventilation and CNS depression – not for vague or subjective symptoms.</li> </ol>